aTyr Pharma Receives $12,000,000 Series C Funding

  • Feed Type
  • Date
    7/28/2009
  • Company Name
    aTyr Pharma
  • Mailing Address
    3565 General Atomics Court San Diego, CA 92121
  • Company Description
    The company is a biopharmaceutical company developing a novel class of naturally occurring protein biologics for human therapeutics.
  • Website
    http://www.atyrpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    This new investment will be used to expand aTyr Pharma’s discovery and preclinical platforms as well as to continue development of the lead drug candidate.
  • M&A Terms
  • Venture Investor
    Alta Partners
  • Venture Investor
    Cardinal Partners
  • Venture Investor
    Polaris Venture Partners

Trending on Xconomy